Clinical Trials & Results
Search or filter the listing below to find a trial or results of a completed trial.
Showing 10 of 10 Results
All Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.
Clear Filters
A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Completed
- Requirements:
- 18 Years to 50 Years
- Interventions:
- Drug: laquinimod 0.3 | Drug: laquinimod 0.6 | Other: Placebo
Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate Compared to Placebo
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Completed
- Requirements:
- 18 Years to 55 Years
- Interventions:
- Drug: Glatiramer acetate (GA) | Drug: Placebo
Comparing Two Doses of Glatiramer Acetate
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Completed
- Requirements:
- 18 Years to 55 Years
- Interventions:
- Drug: Glatiramer Acetate (GA) 40 mg | Drug: glatiramer acetate 20 mg
Disease Progression Study for the Treatment of RRMS
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Terminated
- Requirements:
- 18 Years to 50 Years
- Interventions:
- Drug: Glatiramer Acetate | Drug: Betaseron | Drug: Rebif
Exploring the Long Term Safety, Tolerability and Clinical Effect of Laquinimod
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Terminated
- Requirements:
- 18 Years to 50 Years
- Interventions:
- Drug: Laquinimod | Drug: Placebo
Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for MS
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Completed
- Requirements:
- 20 Years to 57 Years
- Interventions:
- Drug: Copaxoneֲ®
Safety and Effectiveness of Novantrone Therapy Followed by Copaxone
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Completed
- Requirements:
- 18 Years to 55 Years
- Interventions:
- Drug: glatiramer acetate 20 mg | Drug: glatiramer acetate 20 mg, with mitoxantrone
Safety of New Formulation of Glatiramer Acetate (Song)
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Completed
- Requirements:
- 18 Years and older
- Interventions:
- Drug: Glatiramer Acetate | Drug: Experimental Glatiramer Acetate
Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Terminated
- Requirements:
- 18 Years to 55 Years
- Interventions:
- Drug: Glatiramer Acetate | Drug: Placebo | Drug: Prednisone
Study to Evaluate Laquinimod Compared to Interferon ß-1a Administered by Injection
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Withdrawn
- Requirements:
- 18 Years to 55 Years
- Interventions:
- Drug: Laquinimod | Drug: Avonexֲ®
